Add like
Add dislike
Add to saved papers

Tissue interface pressure and estimated subcutaneous pressures of 11 different pressure-reducing support surfaces.

Decubitus 1992 March
This pilot study examined the pressure-reducing properties of 11 different pressure-reducing devices as compared to a standard hospital mattress. Mean trochanteric and heel pressure readings were obtained on each surface from 13 healthy adult volunteers by using an electropneumatic pressure transducer (Gaymar, catalog # PSM1). Mean trochanteric pressures ranged from 37.2 mm Hg to 55.1 mm Hg on the pressure-reducing support surfaces as compared to 83.6 mm Hg on a standard hospital mattress. Mean heel pressure readings ranged from 28.1 mm Hg to 62.1 mm Hg on the pressure-reducing support surfaces as compared to 93.9 mm Hg on the standard hospital mattress. While pressure-reducing support surfaces were found to yield significantly lower mean pressure readings than the standard hospital mattress, none of them is capable of preventing tissue ischemia if the subcutaneous pressure is three to five times higher than the interface pressure.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app